Xarelto Lawsuit Consolidation Occurs Forming MDL 2592

June 01, 2016 – – TheProductLawyers.com reports on Xarelto bleeding lawsuits that have been filed in many federal courts across the country under the jurisdiction of Hon. U.S. District Judge Eldon E. Fallon. The over 2,800 cases have also been consolidated by the U.S. Judicial Panel on Multidistrict Litigation (JPML) as of December 2015 since all of the cases encompass very similar allegations. This consolidation facilitates quicker litigation since discovery issues and conflicting rulings by multiple pre-trial judges is avoided and greatly lessens litigation costs and time expended by those persons involved in each case.

After the hearing held on December 4, 2015, the Judicial Panel arrived at the conclusion that due to the considerable amount of cases coming forth about Xarelto, litigating the multitude of cases on an informal basis would not be a practical solution and would only serve to burden those litigating all of the cases separately. The panel also stated that Judge Eldon Fallon was very accustomed to the multi-district litigation and would be able to provide the leadership needed to properly direct the consolidation proceedings.

The consolidation was spearheaded by a group of plaintiffs in a request dated October 2015 that asked that the cases be overseen in the Southern District of Illinois. Defendants in the case such as Bayer AG and Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson Corporation, resisted the move to Illinois since they are located in New Jersey.

With the formation of the MDL, it is likely that more complaints will be filed by Xarelto patients that have used the blood thinner claiming that they have suffered dangerously uncontrolled bleeding episodes. After the initial creation of MDL 2592, the number of cases included in the consolidated litigation process increased and are expected to grow as the cases in this MDL awaits trial.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010362